Mycobacterium tuberculosis review
By Boyu Yang
Introduction
Mycobacterium tuberculosis(Figure.1) is a deadly human pathogen that has a staggering impact globally, causing infection disease called tuberculosis (TB). According to the Centers for Disease Control and Prevention, eight million people around the world become sick with TB and there are over two million TB-related deaths worldwide each year.[3] However, most of the infection is latent and only 5 to 10% of this population has a lifetime risk of developing active tuberculosis, either within 1 or 2 years after infection (primary tuberculosis) or thereafter (secondary tuberculosis) [4]
Mycobacterium tuberculosis is a weakly gram-positive, non-motile, rod-shaped bacterium. It is also a facultative intracellular parasite as well as an obligated aerobic. This explains why tuberculosis is a disease typically affects the lungs. Unlike other bacteria that have cell walls mainly composed of peptidoglycan, the major cell wall component of mycobacterium is lipids(Figure.2). The lipid layer makes it impervious for gram staining, and it shows either gram-positive or gram-negative. More advance methods like acid-fast staining applied to detect the function of Mycobacterium.[5]
Mycobacterium tuberculosis has a low generation time; cell division occurs every 18-24 hours, which is extremely slow compared with other bacteria that normally has a division rate every 20 minutes.[6] The reason is that the mycolic acid has a low permeability which can protects bacterium taking damage from the immune system such as phagosome and macrophage. However, the impervious characteristic also limits nutrient accessibility, decreasing the rate of diffusion and eventually leads to a slower growth rate.
Mycobacterium tuberculosis cell wall structure
Mycolic acid
Mycolic acids,2-alkyl, 3-hydroxy long-chain fatty acids (FAs), are major and specific lipid components of the mycobacterial cell envelope that account for up to 60% of the whole cell dry weight. They are essential for the survival of members of the genus Mycobacterium.[9]In Mycobacterium tuberculosis cell wall, Mycolic acid can be divided into three categories: alpha-myolic acid, methoxyl-myolic acid, and ketone-myolic acid (figure.3). Alpha-mycolic acid has composed more than 70% of the mycolic acid in M. tuberculosis. It is a pure long alkyl chain attached with several cyclopropanes that contribute to the structural integrity of the cell wall complex and protect the bacillus from oxidative stress.[10] Methoxyl-myolic acid made up to 10% to 15% of the mycolic acid. It has extra methoxyl group connected with fatty acid chain. The rest of the 10% to 15% mycolic acid is ketone mycolic acid which has some extra ketone groups attached on fatty acid.[11] Deletion of those cyclopropane rings would lead to significant attenuation in growth and deletion of the keto-mycolates would lead to restricted growth in macrophages.[12] Thus it is highly associated with virulence of Mycobacterium tuberculosis.
The presence of mycolic plays a significant role in obstructing hydrophilic antimicrobials.[13] Because of this property, hydrophobic antibiotic like rifampicin and fluoroquinolones may be able to cross the cell wall by diffusion. However, the majority of the hydrophilic nutrients and antibiotics like isoniazid are not to diffuse through the lipid layer and they are considered to porin channel instead.[14] Mycobacterium tuberculosis has less abundant than other bacteria and allow a slow uptake rate of nutrient and antibiotic, making it highly resistant to all kinds of antibiotic. Besides resistance to antibiotics, hydrophobic mycolic cell wall also enables tuberculosis to survive inside the macrophage by inhibiting the action of cation proteins, lysozymes, and oxygen radicals, hiding them from the host immune system.
Cord factors
Cord factors (trehalose 6,6′-dimycolate; TDM)is a glycolipid molecule also presence in the cell wall of mycobacterium (figure.3). It locates at the exterior parts of the cell wall and influences the arrangement of mycobacterium into long rod shape, giving it name.[15]
Cord factor is formed by a trehalose sugar and a disaccharide that esterified to two mycolic acid (Figure 4).[16] One of the monosaccharides is connected with mycolic acid at its six carbon and the other monosaccharides also connected with mycolic acid at its six-carbon.[17] Thus, it is named as trehalose 6,6-dimycolate.
Cord factor is extremely toxic to mammalian and it can inhibit polymorphonuclear cell, a category of white blood cells with varying shape of nucleus, migration to the affected area where the infection is present.(10.5) Cord factor could also stimulate the production of TNF (tumor necrosis factors) secretion from the macrophage and T cell. This would lead to a low-grade fever in the infected individuals following by anorexia and eventually result in weight loss. Furthermore, cord factor can induce granuloma formation by its ability to stimulate cytokine production from inflammatory cells in the host.[18]
Wax-D
Wax-D is a lipid complex composed by LAM, sulfatides, and glycolipids and it presents an essential role in preventing oxidation burst inside the phagosome. Sulfatides and glycolipids help mycobacterium tuberculosis in attaching to the macrophages and thusinhibiting the phagosome lysosome fusion. Wax-D also regulates internal acidity by preventing hydrogen ion entering the phagosome, ensuring its DNA replication.[19]
Clinical behavior
Primary infection
Primary infection, the initial phase, occurs in people without specific immunity, generally normal children and young adults who have not previously been exposed to Mycobacterium tuberculosis.[21] It occur when the inhaled bacteria enter the lung would enter the terminal air space and replicate at alveolar macrophage.[22] Some of the infected macrophage would migrate to the close lymph node, and eventually disseminate the infection to remote body parts. Primary infection can be tested by observing the present of granuloma, collection of macrophage ,at the infected area (Figure 5). Primary infection can developed into either latent infection or progressive primary infection. Latent infection take place when the M. tuberculosis have been eliminated by the innate immune system or switch into dormant stage and it is hard to differentiate those two stage based on x ray. Progressive primary infection is observed in 5-10% of patients with primary tuberculosis. Just as its name, the infection gradually worsen and worsen at the 1-2 year of the infection. This infection is developed when the immune system failed to control the out break of virus and it is usually happens at the newborn infant whose immune system is underdeveloped[21].
secondary infection
Secondary infection represent the reactivation of a prior latent or dormant infection and there are 5% to 10% of the secondary infection developed from the latent infection. Secondary infection could occur at any point of the host life, either in several months to decades. There are many factors that governs the occurrence of secondary infection, including the immune state of the host. When the host has experience immunity depression, their likelihood to have a secondary infection is high. Secondary infection is alway with other factors. Patients coinfected with Human immunodeficiency virus (HIV), organ transplant, and IVDU have more than 10-fold risk than the general population. Besides reactivation, secondary infection can also be caused by reinfection through bacteria outside the host.
treatment and prevention
The abundance and diversity of hopanoid lipids positively influence bacterial resistance to environmental stress, such as the extreme pH, high pressure, non-optical temperature, and high concentration of antibiotic or other lethal chemical compounds.[24] With the help of hopanoid lipids, microbiomes develop different strategies to increase the fitness in non-optical environments. However, most of the detailed mechanisms of stress tolerance induced by the hopanoid lipids remain unclear and require further studies.[24]
Medical treatment of tuberculosis, together with correct diagnosis, plays an essential in the management and control of tuberculosis. ()Until now, there are no specific single drugs to eliminate mycobacterium tuberculosis. A combination of two stage multiple stage drug therapy is the most common method used on tuberculosis treatment. Adherence to long-term antituberculosis therapy is crucial for maintaining adequate blood drug level and drug resistance can easily evolve from mycobacterium tuberculosis if the patients apply durg inadequately()
In general, there are two different steps in the treatment of tuberculosis can be recognized, the initial (bactericidal) phase and the continuation (sterilizing) phase. The initial phase treatment usually takes place at the first two month of the treatment in which mycobacteria with a high replication rate are killed, and, consequently, with the histological pulmonary restoration and the reduction of the inflammation process, symptoms and clinical signs resolve (clinical recovery) () The initial phase is also known as intensive phase as most of the drugs like , rifampin, Isoniazid, pyrazinamide, and ethambutol, are applied in the treatment. The continuation phase take place at the next four months after initial treatment. It is oriented to the elimination of semi-dormant mycobacteria. Compared with bacteria at the beginning of the therapy, semi-dormant mycobacteria has a lower replication rate and may exist a low probability of antibactericidal resistance. A patient in continuous phase looks close like a healthy individual. However, without proper drug usage like stop applying drugs, drug resistance mycobacteria may regrow, making treatment become a challenge. The drug combinations commonly used in continuous stages are rifampin and isoniazid. The mode of action of rifampicin in M. tuberculosis is by binding to the β-subunit of the RNA polymerase, inhibiting the elongation of messenger RNA () soniazid acts by inhibiting the synthesis of mycolic acids through the NADH-dependent enoyl-acyl carrier protein (ACP)-reductase, encoded by inhA ()
Nitrogen fixation
Various bacteria, with the ability to produce hopanoids, can fix nitrogen. Bacteria, such as Beijerinckia, Frankia, Anabaena, Burkholderia, etc., show a positive correlation between the hopanoid production and nitrogen fixation.[24] Most nitrogen-fixing bacteria live in close physical correlations with plants, such as alfalfa, soil beans, peas, etc. Both bacteria and plants can take advantage of this relationship. Bradyrhizobium spp. derive energy and other important chemical cofactors from their host plants. The plants also can protect bacteria from stress from the environments, such as competitions with other microbiomes, high proton concentration, etc. Equally, plants benefit from the nitrogen oxides produced by the nitrogen-fixing bacteria, and therefore plants show an enhanced growth rate and outcompete their competitors. There are also free-living nitrogen-fixing microbes, such as Anabaena spp., Frankia spp., etc. However, most of those bacteria do not fix nitrogen without coexisting with plants.
The legume-rhizobia root nodule symbiosis is among one of the most widely studied plants and bacteria associations. The production of hopanoid lipids influences the bacterial symbiosis with the host plants. The Bradyrhizobium spp., with shc mutation, produce a negligible amount of hopanoid lipids. Therefore, this bacteria strain is incapable of integrating with plants. Additionally, different types of hopanoid lipid contribute differently to the bacterial associations with plants. The Bradyrhizobium diazoefficiens with a hpnP mutation cannot produce the extended hopanoids. Their association with the Aeschynomene afraspera results in morphologically disorganized nodules. The Aeschynomene afraspera shows nitrogen starvation, indicating a decreased nitrogen-fixing ability of the hpnP mutant. However, the hpnH mutant, which have less production of 35 carbon hopanoids, cannot form a mature nodule (Figure 14).[25].
The presence of the hopanoid lipids might also contribute to the competition between bacteria to inhabit the hosts. The mutation strain shc, which produces no hopanoid lipids shows an inability in long-term colonization of a plant. Previous studies found that in the beginning, shc mutant grew and developed in host normally. However, after a few days, it started to degenerate and be recycled by its host. On the other hand, the high concentration of hopanoid lipids increases bacterial stress tolerances. For example, the Bradyrhizobium and Burkholderia, both of which contain a high concentration of hopanoid lipids, show resistance to high temperature and low pH conditions. Therefore, in the consideration of global warming and increasing soil acidity, both bacteria might outcompete other bacteria in soil and plants.
Most of the time, bacteria conduct nitrogen fixation in the low-oxygen concentration environment. Nitrogenase, the core enzyme in nitrogen fixation, is vulnerable in the presence of oxygen. Thus, most of the nitrogen-fixing bacteria exist under the anaerobic environment. Sometimes, nitrogen fixation can also be conducted at high oxygen concentration. Under this condition, bacteria need to develop more sophisticated mechanisms to protect the nitrogenase and achieve nitrogen fixation. The free-living nitrogen-fixing bacteria, Azotobacter vinelandii, develop various ways to fix nitrogen under high oxygen condition. For example, the Azotobacter vinelandii decrease its cellular surface area. Therefore, for each unit of cytoplasm, there are larger protections from the bacterial membranes. Also, under high oxygen condition, it also increased its oxygen consumption via keeping a high respiration rate, thus creating an optional anaerobic environment for nitrogen fixation. The Azotobacter vinelandii also synthesizes alginate to create an alginate capsule, a thick barrier which limits the oxygen fission and protects the nitrogenase from the high oxygen-concentrated surroundings. Under the lower oxygen concentrated environment, Azotobacter vinelandii develops a loose alginate capsule, while under the high concentration, it builds up a compact and thick alginate capsule (Figure 15). Additionally, when the bacteria interact with or inhabit plants, the host plants synthesize leghemoglobin molecules, one type of oxygen-transport metalloproteins. This hemoglobin scavenges oxygen from the root nodules of the leguminous plants, creating an optimal environment for nitrogenase activity[26].
Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2018, Kenyon College.
- ↑ Slonczewski, J., and Foster J. W.. Microbiology: An Evolving Science. New York
- ↑ Martynov AV, Bomko TV, Nosalskaya TN, Lisnyak Yu.V, Romanova EA, Kabluchko TV, … Farber SB. (2016). TUBERCULOSIS AS AN INFECTIOUS PATHOLOGY OF IMMUNE SYSTEM. Annals of Mechnikov Institute, (3), 8–14. http://doi.org/10.5281
- ↑ uni Takayama,1,2,3,* Cindy Wang,1 and Gurdyal S. Besra4Clin Microbiol Rev. Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis 2005 Jan; 18(1): 81–101.doi: 10.1128/CMR.18.1.81-101.2005
- ↑ Reinout van Crevel, Tom H. M. Ottenhoff, Jos W. M. van der Meer,Innate Immunity to Mycobacterium tuberculosis,DOI: 10.1128/CMR.15.2.294-309.2002
- ↑ Cudahy P, Shenoi SV (April 2016). "Diagnostics for pulmonary tuberculosis". Postgraduate Medical Journal. 92 (1086): 187–93. doi:10.1136/postgradmedj-2015-133278.
- ↑ Cudahy P, Shenoi SV (April 2016). "Diagnostics for pulmonary tuberculosis". Postgraduate Medical Journal. 92 (1086): 187–93. doi:10.1136/postgradmedj-2015-133278.
- ↑ Kuni Takayama,1,2,3,* Cindy Wang,1 and Gurdyal S. Besra, Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis,doi: 10.1128/CMR.18.1.81-101.2005
- ↑ Hopane Reference Standards for use as Petrochemical Biomarkers in Oil Field Remediation and Spill Analysis, Amann N., Sigma Aldrich, Accessed May 11th, 2018
- ↑ M. Daffé, P. DraperThe envelope layers of mycobacteria with reference to their pathogenicityDOI: 10.1016/s0065-2911(08)60016-8
- ↑ Yuan Y, Lee RE, Besra GS, Belisle JT, Barry CE 3rdProc Natl Acad Sci U S A. 1995 Jul 3; 92(14):6630-4.dentification of a gene involved in the biosynthesis of cyclopropane mycolic acids in Mycobacterium tuberculosis.doi: 10.1073/pnas.92.14.6630
- ↑ dentification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.Yuan Y, Lee RE, Besra GS, Belisle JT, Barry CE 3rdProc Natl Acad Sci U S A. 1995 Jul 3; 92(14):6630-4.
- ↑ Yuan Y, Zhu Y, Crane DD, Barry CE 3rd,he effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis.dOI: 10.1046/j.1365-2958.1998.01026.x
- ↑ Draper, P. (1998) The outer parts of the mycobacterial envelope as permeability barriers. Frontiers of Biosciences 3, 1253–1261
- ↑ rias, J., Jarlier, V. and Benz, R. (1992) Porins in the cell wall of mycobacteria. Science 258, 1479–1481DOI: 10.1126/science.1279810
- ↑ Saita, N.; Fujiwara, N.; Yano, I.; Soejima, K.; Kobayashi, K. (1 October 2000). "Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Corneal Angiogenesis in Rats". Infection and Immunity. 68 (10): 5991–5997. doi:10.1128/IAI.68.10.5991-5997.2000.
- ↑ OLL, H; BLOCH, H; ASSELINEAU, J; LEDERER, E (May 1956). "The chemical structure of the cord factor of Mycobacterium tuberculosis". Biochimica et Biophysica Acta. 20 (2): 299–309. doi:10.1016/0006-3002(56)90289-x.
- ↑ OLL, H; BLOCH, H; ASSELINEAU, J; LEDERER, E (May 1956). "The chemical structure of the cord factor of Mycobacterium tuberculosis". Biochimica et Biophysica Acta. 20 (2): 299–309. doi:10.1016/0006-3002(56)90289-x.
- ↑ Perez RL, Roman J, Staton GW Jr, Hunter RL,Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.DOI: 10.1164/ajrccm.149.2.8306054
- ↑ Saita, N.; Fujiwara, N.; Yano, I.; Soejima, K.; Kobayashi, K. (1 October 2000). "Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Corneal Angiogenesis in Rats". Infection and Immunity. 68 (10): 5991–5997. doi:10.1128/IAI.68.10.5991-5997.2000.
- ↑ Rotimi Adigun; Rahulkumar Singh,Tuberculosis NCBI
- ↑ 21.0 21.1 Dempers, M.B.Ch.B., F.C. For. Path. (S.A.), Dip. For. Med. (S.A.), CML (Unisa),a Mary Ann Sens, M.D., Ph.D.,b Shabbir Ahmed Wadee, B.Sc., M.B.Ch.B., M.Med.(For Path.), F.C. For Path.(S.A.),c Hannah C. Kinney, M.D.,d Hein J. Odendaal, M.B.Ch.B., M.Med., F.C O.G.(S.A.), F.R.C.O.G., M.D,e Colleen A. Wright, M.D., M.Med. (Anat. Path.), F.C. Path. (S.A.), F.R.C.Path., F.I.A.C., Ph.D.,f and the PASS NetworkProgressive Primary Pulmonary Tuberculosis Presenting as the Sudden Unexpected Death in Infancy: A Case Report 2010 Aug 11. doi: 10.1016/j.forsciint.2010.07.018
- ↑ Michael S. Glickman* and William R. Jacobs, Jr. Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Disciplinehttps://doi.org/10.1016/S0092-8674(01)00236-7
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedWelander2009
- ↑ 24.0 24.1 24.2 Cite error: Invalid
<ref>
tag; no text was provided for refs namedBelin2018
- ↑ 25.0 25.1 25.2 Kulkarni G., Busset N., Molinaro A., Gargani D., Chaintreuil C., Silipo A., Giraud E., and Newman D. K.. 2015. Specific Hopanoid Classes Differentially Affect Free-Living and Symbiotic States of Bradyrhizobium diazoefficiens. mBio 6(5):e01251-15. doi:10.1128/mBio.01251-15.
- ↑ Sabra W., Zeng A. P., Lunsdorf H., and Deckwer W. R.. 2000. Effect of Oxygen on Formation and Structure of Azotobacter vinelandii Alginate and Its Role in Protecting Nitrogenase. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Sept. 2000, Vol. 66, No. 9, p. 4037–4044